BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8481928)

  • 1. Prospects for gene-directed therapy with antisense oligodeoxynucleotides.
    Calabretta B; Skorski T; Szczylik C; Zon G
    Cancer Treat Rev; 1993 Apr; 19(2):169-79. PubMed ID: 8481928
    [No Abstract]   [Full Text] [Related]  

  • 2. First antisense drug trials planned in leukemia.
    Reynolds T
    J Natl Cancer Inst; 1992 Mar; 84(5):288-90. PubMed ID: 1738177
    [No Abstract]   [Full Text] [Related]  

  • 3. Antisense strategies in the treatment of leukemias.
    Calabretta B; Skorski T; Ratajczak MZ; Gewirtz AM
    Semin Oncol; 1996 Feb; 23(1):78-87. PubMed ID: 8607034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prospects for antisense therapy of human leukemias].
    Maekawa T
    Hum Cell; 1996 Mar; 9(1):17-24. PubMed ID: 9183625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic applications of antisense DNA in the treatment of human leukemia.
    Gewirtz AM
    Ann N Y Acad Sci; 1992 Oct; 660():178-87. PubMed ID: 1285070
    [No Abstract]   [Full Text] [Related]  

  • 6. Antisense therapy.
    Narayanan R; Akhtar S
    Curr Opin Oncol; 1996 Nov; 8(6):509-15. PubMed ID: 8971471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oncogenes and pharmacological approaches to cancer therapy].
    Tocque B
    Pathol Biol (Paris); 1992 Nov; 39(9):869-70. PubMed ID: 1538914
    [No Abstract]   [Full Text] [Related]  

  • 8. Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides.
    Hélène C
    Eur J Cancer; 1991; 27(11):1466-71. PubMed ID: 1835863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic potential of antisense oligonucleotides.
    Sharma HW; Narayanan R
    Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides.
    Skorski T; Nieborowska-Skorska M; Wlodarski P; Perrotti D; Hoser G; Kawiak J; Majewski M; Christensen L; Iozzo RV; Calabretta B
    J Natl Cancer Inst; 1997 Jan; 89(2):124-33. PubMed ID: 8998181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense therapy in cancer.
    Pawlak W; Zolnierek J; Sarosiek T; Szczylik C
    Cancer Treat Rev; 2000 Oct; 26(5):333-50. PubMed ID: 11006135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of antisense oligonucleotides in oncology.
    Pierga JY; Magdelenat H
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):237-61. PubMed ID: 7920172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.
    Ratajczak MZ; Kant JA; Luger SM; Hijiya N; Zhang J; Zon G; Gewirtz AM
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11823-7. PubMed ID: 1281545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense strategies for oncogene inactivation.
    Stein CA; Benimetskaya L; Mani S
    Semin Oncol; 2005 Dec; 32(6):563-72. PubMed ID: 16338422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing oligonucleotide therapeutics for human leukemia.
    Gewirtz AM
    Anticancer Drug Des; 1997 Jul; 12(5):341-58. PubMed ID: 9236851
    [No Abstract]   [Full Text] [Related]  

  • 16. Protein kinase A-directed antisense restrains cancer growth: sequence-specific inhibition of gene expression.
    Cho-Chung YS
    Antisense Nucleic Acid Drug Dev; 1996; 6(3):237-44. PubMed ID: 8915509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications.
    Calabretta B
    Cancer Res; 1991 Sep; 51(17):4505-10. PubMed ID: 1873794
    [No Abstract]   [Full Text] [Related]  

  • 18. Antisense of oligonucleotides and the inhibition of oncogene expression.
    Prins J; de Vries EG; Mulder NH
    Clin Oncol (R Coll Radiol); 1993; 5(4):245-52. PubMed ID: 8398922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense strategies for the treatment of hematological malignancies and solid tumors.
    Kronenwett R; Haas R
    Ann Hematol; 1998; 77(1-2):1-12. PubMed ID: 9760146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense strategy in hematological malignancies.
    Warzocha K
    Cytokines Cell Mol Ther; 1999 Mar; 5(1):15-23. PubMed ID: 10390076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.